Cue Biopharma Ownership | Who Owns Cue Biopharma?

Overview Forecast RevenueFinancials Chart

Cue Biopharma Ownership Summary

Cue Biopharma is owned by 34.14% institutional investors, 19.67% insiders, and 46.18% retail investors. Driehaus capital management is the largest institutional shareholder, holding 6.08% of CUE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.66% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cue Biopharma	34.14%	19.67%	46.18%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Driehaus capital management	292.14K	6.08%	$9.22M
Vanguard group	3.01M	2.99%	$919.28K
Ikarian capital	104.36K	2.17%	$3.29M
Tfg asset management gp	93.82K	1.95%	$2.96M
Blackrock	756.74K	1.53%	$938.35K
Stempoint capital lp	67.00K	1.39%	$2.11M
Adar1 capital management	55.19K	1.15%	$1.74M
Boothbay fund management	31.46K	0.65%	$992.85K
Citadel advisors	25.63K	0.53%	$808.98K
Two sigma securities	39.51K	0.04%	$28.40K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tfg asset management gp	93.82K	0.47%	$2.96M
Stempoint capital lp	67.00K	0.36%	$2.11M
Ikarian capital	104.36K	0.35%	$3.29M
Adar1 capital management	55.19K	0.08%	$1.74M
Driehaus capital management	292.14K	0.05%	$9.22M
Boothbay fund management	31.46K	0.01%	$992.85K
Two sigma securities	39.51K	0.00%	$28.40K
New millennium group	5.75K	0.00%	$1.76K
Tower research capital llc (trc)	869.00	0.00%	$27.43K
Tidemark	50.00	0.00%	$1.58K

Top Buyers

Holder	Shares	% Assets	Change
Driehaus capital management	292.14K	0.05%	292.14K
Ikarian capital	104.36K	0.35%	104.36K
Tfg asset management gp	93.82K	0.47%	93.82K
Stempoint capital lp	67.00K	0.36%	67.00K
Adar1 capital management	55.19K	0.08%	55.19K

Top Sellers

Holder	Shares	% Assets	Change
Bleichroeder lp	-	-	-6.82M
Catalytic wealth ria	-	-	-4.63M
Vanguard capital management	-	-	-2.46M
Slate path capital lp	-	-	-2.40M
Lion point capital, lp	-	-	-2.20M

New Positions

Holder	Shares	% Assets	Change	Value
Driehaus capital management	292.14K	0.05%	292.14K	$9.22M
Ikarian capital	104.36K	0.35%	104.36K	$3.29M
Tfg asset management gp	93.82K	0.47%	93.82K	$2.96M
Stempoint capital lp	67.00K	0.36%	67.00K	$2.11M
Adar1 capital management	55.19K	0.08%	55.19K	$1.74M

Sold Out

Holder	Change
Assetmark	-2.00
Jpmorgan chase	-4.00
Nelson, van denburg & campbell wealth management group	-7.00
Farther finance advisors	-43.00
Innealta capital	-49.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	51	-5.56%	1,641,446	-92.33%	34	15.53%	18	-	30	200.00%
Mar 31, 2026	39	-18.75%	17,477,330	-19.79%	16	3.47%	11	-26.67%	7	-36.36%
Dec 31, 2025	43	-17.31%	19,047,417	5.47%	18	5.28%	13	-13.33%	10	-23.08%
Sep 30, 2025	49	8.89%	18,058,423	4.34%	18	5.75%	14	-17.65%	13	44.44%
Jun 30, 2025	46	-9.80%	17,348,745	52.15%	18	7.71%	18	12.50%	9	-30.77%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	111.87K	2.66%	18.50K
Vanguard Morn Total Stk Mkt Idx Investor	111.87K	2.66%	18.50K
Vanguard US Total Market Shares ETF	1.35M	2.18%	-1.00
Vanguard MStar Total Stk Mkt Idx Invest	111.87K	2.14%	-
Vanguard Institutional Extnd Mkt Idx Tr	47.09K	0.90%	-
Fidelity Extended Market Index	21.06K	0.50%	5.03K
BlackRock Extended Equity Market Fund K	11.08K	0.26%	7.72K
iShares Micro-Cap ETF	10.98K	0.26%	-146.00
Spartan Extended Market Index Pool F	8.11K	0.19%	5.05K
Fidelity Total Market Index	7.26K	0.17%	1.48K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 13, 2026	Ray Sumita	Chief Legal Compliance Officer	Sell	$124.52
Aug 13, 2026	Ray Sumita	Chief Legal Compliance Officer	Sell	$195.51K
Aug 13, 2026	Ray Sumita	Chief Legal Compliance Officer	Sell	$69.99K
Aug 13, 2026	Meluzio Michael Vincent	VP, Prin. Accounting Officer	Sell	$44.61K
Aug 13, 2026	Meluzio Michael Vincent	VP, Prin. Accounting Officer	Sell	$124.62K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	5
2026 Q2	2	-
2026 Q1	-	-
2025 Q4	5	-
2025 Q3	-	-

CUE Ownership FAQ

Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 34.14%, followed by 19.67% insiders and 46.19% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 379.01%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Driehaus capital management (292.14K shares, 6.08%), Vanguard group (3.01M shares, 2.99%), and Ikarian capital (104.36K shares, 2.17%). Together, they hold 11.24% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Tfg asset management gp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 93.82K Cue Biopharma shares, valued at 2.96M$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cue Biopharma shares, with 2.66% of its total shares outstanding invested in 111.87K Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools